Answers are grounded in this paper and cite their sources.
To the Editor, We read with great interest an article by Kini et al.1 where the authors drew attention to myocardial injury as a complication of COVID-19 (the authors cited data from 2020 when the contagious delta variant was not prevalent yet). We believe that the burden of cardiac complications will be much higher since the latest data report a 16 times greater risk of myocarditis in people suffering from COVID-19, which in turn will increase the incidence of myocardial injury.2 Moreover, an analysis of a fifth of the US population shows that men between 12 and 17 years of age most likely develop myocarditis in the first 12 months of the pandemic or within 3 months of SARS-CoV-2 infection, with an incidence of approximately 450 per million infections.3 It is also important to note that currently the number of infected teenagers in the USA is the highest among all age groups. These data suggest that myocardial injury will be more common not only in the acute phase of SARS-CoV-2 infection, but also in the chronic phase i.e. long COVID-19 syndrome, in the near future. Conflict of interest: none declared. None.
No takes yet. Share an insight, caveat, or question.
Szarpak et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: